Verseon Corp (LON:VSN) insider Fodor,Eniko acquired 6,000 shares of the stock in a transaction that occurred on Wednesday, September 21st. The stock was acquired at an average cost of GBX 161 ($2.10) per share, for a total transaction of £9,660 ($12,609.32).

Verseon Corp (LON:VSN) opened at 156.00 on Wednesday. Verseon Corp has a 52-week low of GBX 148.00 and a 52-week high of GBX 230.00. The company’s market capitalization is GBX 236.16 million. The company has a 50-day moving average price of GBX 161.00 and a 200 day moving average price of GBX 163.16.

Verseon Corp Company Profile

Verseon Corporation is a pharmaceutical company. Its platform is capable of modeling interactions between a protein and a drug molecule with precision sufficient for designing drug candidates. The Company operates through pharmaceutical research segment. The Company uses its drug discovery technology to develop a portfolio of programs targeting disease areas consisting of anti-coagulation, diabetic macular edema (DMA) and oncology.

Receive News & Ratings for Verseon Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verseon Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.